Decoding the means
to cancer’s end

Since our beginning in 2014, Freenome has had a clear vision— building a multi-disciplinary team with expertise in computational biology and machine learning techniques to reinvent disease management through early detection and precision intervention. 

In this way, we seek to radically transform the way patients with cancer are managed, equipping people everywhere with the knowledge and tools they need to maintain a healthier life, and one day, prevent cancer altogether.


We are technologists

We are programmers, machine learning experts, and computational biologists developing early cancer detection blood tests powered by our multiomics platform.

We are scientists

We are molecular biologists, clinicians and sequencing experts working together to ensure the highest quality of scientific research and develop the infrastructure necessary for next-generation early cancer detection and precision treatments.

We are people

All of us have been touched by cancer. Our experiences as patients and people lend urgency and meaning to the work we do every day, motivating us to equip all individuals and families with the tools they need to detect and treat cancer at its earliest and most manageable stages.